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Pheochromocytoma with IVC Invasion: A Case Report and 
Systematic Literature Review
Jennifer Kim; David G Schutter, MD; Gitonga Munene, MD, FACS
Western Michigan University Homer Stryker M.D. School of Medicine
Abstract
Background: Surgical management and outcome of pheochromocytoma with invasion of the
inferior vena cava (IVC) has been scarcely reported in the literature. As surgical resection of
this condition is underrepresented, we include a case report and a systematic literature review.
Results: A literature search in PubMed yielded 29 case reports between 1969 and 2014. With
the inclusion of our new case report, the mean age of the patients was 43.3 years, with 33%
being female (n=10) and 67% being male (n=20). 77% (n=23) of the cases were right-sided
pheochromocytomas that invaded the IVC, with only one case localized in the organ of
Zuckerkandl. For diagnosis, both laboratory tests and imaging modalities were used. 77%
(n=23) reported using laboratory tests (serum and urine metabolites) to diagnose
pheochromocytoma while 83% (n=25) reported using various imaging modalities to localize the
extent of the tumor prior to surgery. On average, 2-3 different imaging types were used per
case. Of the 25 cases that used imaging diagnostics, 80% (n=20) were able to detect IVC
invasion prior to operation. Pre-operative treatment was reported in only 37% of the cases.
Surgical approach via sternotomy, thoracophrenolaparotomy, or thoracoabdominal approaches
were used to completely resect the tumor and IVC. Aggressive surgical tumor and IVC
resections resulted in excellent post-operative outcomes with 0% recurrence and four deaths
unrelated to the operation.
Conclusion: Pheochromocytoma with IVC involvement is curable with surgical resection.
Multiple imaging modalities should be used to confirm IVC involvement and/or metastases to
other organs. However, malignant characteristics of pheochromocytoma still have yet to be
defined clearly and management of these cases need to be reported more consistently.
Introduction
Pheochromocytoma is a catecholamine- producing neoplasm of the adrenal gland that, if left
untreated or missed, is likely fatal.20 Pheochromocytomas are highly vascularized and can
spread intravenously to adjacent adrenal veins, renal veins and, rarely, to the inferior vena cava
and into the right atrium. A majority of pheochromocytomas are benign, however, 10-15% of
these adrenal tumors can be malignant, with an overall 5-year survival of 40-50%. Currently,
according to WHO, malignant pheochromocytoma is defined by distant metastases at sites
where chromaffin is otherwise unlikely to be found.28 Thus, tumor extension into the IVC does
not necessarily indicate malignancy.16 Invasion into the IVC may be via direct tumor invasion of
the venous wall or from tumor extension via small draining veins.17
Although aggressive surgical resection has been indicated as the treatment of choice for these
cases, surgical management of pheochromocytoma with IVC invasion is scarcely reported
likely due to its low incidence.24 Thus, surgical management of these rare cases have been
variable and challenging. We give a comprehensive review of the diagnosis, localization, and
surgical management of pheochromocytomas with IVC invasion in hopes to assess the most
effective management strategy.
Methods
A literature search was conducted and yielded 29 cases between 1969 and 2014. Data was
extracted based on the following variables: patient’s age, gender, labs, size and laterality of the
tumor, IVC invasion, preoperative treatment and imaging, preoperative procedures, and
oncological outcomes.
Case Report
A 21 year old female presented to the ED with a 1 month history of headache, sweating and
anxiety. Plasma metanephrines were elevated at 71 nmol/L. A CT abdomen/pelvis with and
without contrast detected a mass of 9.8x7.7x7.6 cm from the right adrenal gland. It did not
appear to invade the kidney or liver, but that could not be ruled out. Invasion of the IVC without
extra vessel invasion was noted. She was referred to our Surgical Oncology clinic and deemed
suitable for resection. Pre-operatively, her β-blocker was discontinued and she was treated with
Doxazosin, an α1-blocker. An open right adrenalectomy via abdominal approach and en bloc
adrenalectomy with IVC resection were performed. Post-operatively, the patient had no
complications and was discharged on post-op Day 4. Since discharge, she has had no
recurrence of headache, sweating, or hypertension and has discontinued her hypertensive
medications.
Results
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Discussion
Rarely, pheochromocytoma can extend into the IVC through direct caval wall invasion or the venous
drainage system. Our systematic literature review and report of 30 cases in the past five decades
revealed that there has been no consistent reporting of these cases. Only 77% of the cases reported
using serum or urine metabolite tests to diagnose pheochromocytoma when these tests are considered
to be the most reliable way of assessing this condition.12 Compared to pheochromocytoma patients
without IVC involvement, there is a predominant male patient population in cases with IVC
involvement.14 There was also a higher likelihood of a right-sided tumor extending into the IVC, which is
expected due to the direct anatomical convergence of the right adrenal vein into the IVC compared to
the left adrenal vein.
Once pheochromocytoma was diagnosed in patients with serum or urine metabolite tests, pre-operative
imaging was almost universally conducted to localize the tumor. On average, 2-3 different imaging
modalities were used per case to assess the extent and to confirm IVC invasion. The most common
type of imaging was the CT scan, and the most effective, an ultrasound. Only 37% reported the use of α
and/or β blockade even though treatment to control hypertension prior to operation is crucial.
Intraoperative findings revealed variability in surgical techniques depending on the location of the tumor
within the IVC. Post-operatively, patients had great outcomes with 0% recurrence. In fact, the four
documented deaths were due to causes unrelated to the operation itself. For the 26 patients who
survived, however, there was variability in follow-up time lengths with a mean disease-free period of
25.3 months from post-op to most recent follow-up. The discrepancy in follow-up time intervals stresses
the need for more consistent monitoring. Especially since malignancy of pheochromocytomas has yet
to be clearly defined, continuous monitoring of these patients should be considered to prevent the risk
of metastasis in the long-term.
Conclusion
Pheochromocytoma is primarily a surgical disease that can be completely cured with resection of the
tumor, but no other specific recommendations for management can be made at this time. Pre-
operatively, possible invasion into the IVC should be considered when imaging, and multiple modalities
should be used. There is also a need to systematically report such rare cases of IVC involvement for
proper management and clarification of potentially malignant pheochromocytomas.
Limitations
The rarity of this condition and the scarcity of cases reported has made it difficult to compare the
management of these cases. There is inconsistency with data reporting, and malignant
pheochromocytomas lack clear features other than distant metastasis.
Table 1. IMAGING MODALITIES
Imaging Modality No. of studies 
used
No. of IVC 
invasion detected
CT scan
Angiography/Vena Cavography
Ultrasound
MRI
Echocardiography
MIBG
Excretory urography
Chest X-ray
19
14
12
7
3
3
2
1
6
4
6
4
1
0
0
0
Right
77%
Left
17%
Other: Organ of 
Zuckerkandl
3%
Unknown
3%
Males
67%
Females
33%
Figure 2. Male dominance and right-sided tumor laterality in cases of
Pheochromocytomas with IVC invasion.
Table 2. SURGICAL MANAGEMENT
Surgical Management n %
History of recurrent Pheochromocytoma
Pre-operative α-blockade only
Pre-operative α and β blockade
Use of Extracorporeal circulation
IVC reconstruction
7
4
8
6
5
23
13
27
20
17
Figure 1. CT Scan of right-sided Pheochromocytoma and intra-op cavotomy. 
Table 3. POST-OP OUTCOMES
Outcome n %
Survival
Recurrence
Death
26
0
4
87
0
13
